Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;24(1):111-7.
doi: 10.1007/s11606-008-0823-6. Epub 2008 Nov 13.

Update in new medications for primary care

Gerald W Smetana  1 , Jane S Sillman
Affiliations
Review

Update in new medications for primary care

Gerald W Smetana et al. J Gen Intern Med. 2009 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Continuous smoking abstinence rates for varenicline versus bupropion and placebo. Continuous smoking abstinence represents no cigarette smoking at any time during the defined interval. Data from Jorenby DE, Hays JT, Rigotti NA, et al. JAMA. 2006;296:56–63.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. US Food and Drug Administration. Center for Drug Evaluation and Research. Drugs @ FDA. FDA approved drug products. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. Accessed: September 23, 2008.
    1. Department of Health and Human Services. Centers for Disease Control and Prevention. Smoking and tobacco use. Fast facts. Available at: http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm Accessed: September 23, 2008.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.296.1.47', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.296.1.47'}, {'type': 'PubMed', 'value': '16820546', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16820546/'}]}
    2. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296:47–55. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.296.1.56', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.296.1.56'}, {'type': 'PubMed', 'value': '16820547', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16820547/'}]}
    2. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296:56–63. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.296.1.64', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.296.1.64'}, {'type': 'PubMed', 'value': '16820548', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16820548/'}]}
    2. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296:64–71. - PubMed

MeSH terms